Substantial doubt about the company's ability to continue as a going concern.
“Accordingly, management has determined that substantial doubt exists about the Company's ability to continue as a going concern for a period of one year from the date these unaudited condensed financial statements are issued. The accompanying unaudited condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty.”View the 10-Q filed Aug 17, 2026
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Copley Acquisition Corp adjourned the Extraordinary General Meeting to 11:00 a.m. Eastern time on November 2, 2026 to consider up to 12 deadline extensions. The Sponsor will contribute $200,000 per extension; Copley waived dissolution-expense and tax withdrawals from trust interest.
Copley Acquisition Corp adjourned its October 29, 2026 shareholder meeting to November 2, 2026 to vote on up to 12 one-month extensions; Copley Acquisition Sponsors, LLC will contribute $200,000 for each extension.
Copley Acquisition Corp shareholders will vote on October 29, 2026 on extending the business-combination deadline from November 2, 2026 to November 2, 2027 through up to 12 one-month extensions, with $150,000 deposited per extension.
Copley Acquisition Corp mutually terminated its Business Combination Agreement effective October 9, 2026 and will continue pursuing a business combination until November 2, 2026, subject to extension.
Useful current figures from the complete screener profile.
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Illustrative technical + ownership context — a signal mix, not investment advice.
KPI extraction has been attempted, but no publishable series is available from the examined filings. This is not evidence that the company reports no KPIs.
| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
COPL
this stock
Copley Acquisition Corp
|
$235.79M | +3.5% | — | — | 0.0% |
|
VYLR
Vylor Inc.
|
$45.73B | — | — | — | 2.2% |
|
CLUS
Cluster Group Holdings Ltd Co
|
$8.00B | — | — | — | — |
|
DMII
Drugs Made In America Acquisition II Corp.
|
$651.01M | +3.2% | — | — | 0.0% |
|
CCXI
Churchill Capital Corp XI
|
$627.18M | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| COPL | +0.3% | +0.9% | +3.2% | +0.4% | +3.5% |
| SPY | -4.7% | -5.3% | -0.8% | -3.0% | +7.5% |
| vs SPY | +5.0% | +6.1% | +4.0% | +3.4% | -4.0% |
